Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $638.78 | 20 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Medtronic, Inc. | $243.99 | 5 | $0 (2023) |
| Corcept Therapeutics | $83.06 | 1 | $0 (2021) |
| Dexcom, Inc. | $69.71 | 1 | $0 (2023) |
| Xeris Pharmaceuticals, Inc. | $59.08 | 3 | $0 (2023) |
| Lilly USA, LLC | $42.81 | 2 | $0 (2023) |
| Novo Nordisk Inc | $36.62 | 2 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $20.25 | 1 | $0 (2023) |
| Ultragenyx Pharmaceutical Inc. | $19.18 | 1 | $0 (2023) |
| Alexion Pharmaceuticals, Inc. | $17.66 | 1 | $0 (2023) |
| Esperion Therapeutics, Inc. | $16.24 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $525.54 | 17 | Medtronic, Inc. ($243.99) |
| 2021 | $83.06 | 1 | Corcept Therapeutics ($83.06) |
| 2020 | $15.69 | 1 | AstraZeneca Pharmaceuticals LP ($15.69) |
| 2017 | $14.49 | 1 | AbbVie, Inc. ($14.49) |
All Payment Transactions
20 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/09/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.51 | General |
| Category: Diabetes | ||||||
| 10/23/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $17.52 | General |
| Category: Diabetes | ||||||
| 07/05/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $16.21 | General |
| Category: Durable Pump | ||||||
| 05/31/2023 | Medtronic, Inc. | MINIMED 780G (Device) | Food and Beverage | In-kind items and services | $141.60 | General |
| Category: Durable Pump | ||||||
| 04/14/2023 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $15.46 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 04/04/2023 | Alexion Pharmaceuticals, Inc. | STRENSIQ (Biological) | Food and Beverage | In-kind items and services | $17.66 | General |
| Category: Rare Disease | ||||||
| 03/24/2023 | Dexcom, Inc. | DEXCOM G7 GSS (161) (Medical Supply) | Food and Beverage | In-kind items and services | $69.71 | General |
| Category: Endocrinology | ||||||
| 03/20/2023 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $24.05 | General |
| Category: Diabetes | ||||||
| 03/10/2023 | Ultragenyx Pharmaceutical Inc. | — | Food and Beverage | In-kind items and services | $19.18 | General |
| 03/08/2023 | Lilly USA, LLC | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $23.40 | General |
| Category: Diabetes | ||||||
| 03/08/2023 | Lilly USA, LLC | HUMULIN (Drug), MOUNJARO | Food and Beverage | In-kind items and services | $19.41 | General |
| Category: Diabetes | ||||||
| 03/07/2023 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $16.24 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 02/21/2023 | Medtronic, Inc. | MINIMED 770G (Device) | Food and Beverage | In-kind items and services | $53.87 | General |
| Category: Durable Pump | ||||||
| 02/17/2023 | Medtronic, Inc. | INPEN SMART INSULIN DELIVERY SYSTEM (Device) | Food and Beverage | In-kind items and services | $16.85 | General |
| Category: Continuous Glucose Monitoring | ||||||
| 02/11/2023 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $16.11 | General |
| Category: Obesity | ||||||
| 01/18/2023 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.25 | General |
| Category: DIABETES | ||||||
| 01/13/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $20.51 | General |
| Category: Diabetes | ||||||
| 09/28/2021 | Corcept Therapeutics | Korlym (Drug) | Food and Beverage | In-kind items and services | $83.06 | General |
| Category: Endocrinology | ||||||
| 02/27/2020 | AstraZeneca Pharmaceuticals LP | BYDUREON (Drug) | Food and Beverage | In-kind items and services | $15.69 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 07/26/2017 | AbbVie, Inc. | Androgel (Drug), Synthroid | Food and Beverage | In-kind items and services | $14.49 | General |
| Category: Endocrinology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 5 | 348 | 365 | $73,520 | $27,037 |
| 2022 | 7 | 420 | 1,278 | $97,093 | $40,258 |
| 2021 | 6 | 280 | 296 | $55,003 | $15,503 |
| 2020 | 4 | 117 | 118 | $26,982 | $5,830 |
All Medicare Procedures & Services
22 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 128 | 140 | $31,246 | $12,779 | 40.9% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 62 | 62 | $19,674 | $5,796 | 29.5% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 69 | 72 | $12,270 | $4,697 | 38.3% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 44 | 44 | $9,202 | $3,318 | 36.1% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 45 | 47 | $1,128 | $447.44 | 39.7% |
| J0897 | Injection, denosumab, 1 mg | Office | 2022 | 13 | 780 | $35,178 | $13,765 | 39.1% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 98 | 105 | $21,525 | $10,848 | 50.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 115 | 147 | $24,843 | $9,166 | 36.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2022 | 34 | 34 | $6,970 | $2,886 | 41.4% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 19 | 19 | $5,909 | $2,462 | 41.7% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 61 | 81 | $1,884 | $769.85 | 40.9% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2022 | 80 | 112 | $784.00 | $360.44 | 46.0% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 56 | 63 | $13,350 | $4,915 | 36.8% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 84 | 93 | $13,221 | $4,308 | 32.6% |
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 63 | 63 | $18,155 | $3,962 | 21.8% |
| 99204 | New patient outpatient visit, total time 45-59 minutes | Office | 2021 | 19 | 19 | $9,462 | $1,954 | 20.7% |
| 83036 | Hemoglobin a1c level | Office | 2021 | 27 | 27 | $598.00 | $262.17 | 43.8% |
| 82962 | Blood glucose (sugar) test performed by hand-held instrument | Office | 2021 | 31 | 31 | $217.00 | $101.68 | 46.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 52 | 52 | $17,680 | $3,163 | 17.9% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 23 | 23 | $5,500 | $1,415 | 25.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 27 | 28 | $3,562 | $1,109 | 31.1% |
| 83037 | Hemoglobin a1c level | Office | 2020 | 15 | 15 | $240.00 | $142.80 | 59.5% |
About Dr. Sylvester Odeke, MD
Dr. Sylvester Odeke, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in Greenville, North Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/12/2005. The National Provider Identifier (NPI) number assigned to this provider is 1265426787.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Sylvester Odeke, MD has received a total of $638.78 in payments from pharmaceutical and medical device companies, with $525.54 received in 2023. These payments were reported across 20 transactions from 12 companies. The most common payment nature is "Food and Beverage" ($638.78).
As a Medicare-enrolled provider, Odeke has provided services to 1,165 Medicare beneficiaries, totaling 2,057 services with total Medicare billing of $88,628. Data is available for 4 years (2020–2023), covering 22 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism|Endocrinology, Diabetes & Metabolism
- Location Greenville, NC
- Active Since 09/12/2005
- Last Updated 11/28/2018
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1265426787
Products in Payments
- MINIMED 780G (Device) $157.81
- Korlym (Drug) $83.06
- DEXCOM G7 GSS (161) (Medical Supply) $69.71
- GVOKE HYPOPEN (Drug) $59.08
- MINIMED 770G (Device) $53.87
- JARDIANCE (Drug) $43.65
- INPEN SMART INSULIN DELIVERY SYSTEM (Device) $32.31
- Ozempic (Drug) $20.51
- HUMULIN (Drug) $19.41
- STRENSIQ (Biological) $17.66
- NEXLETOL (Drug) $16.24
- Wegovy (Drug) $16.11
- BYDUREON (Drug) $15.69
- Androgel (Drug) $14.49
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in Greenville
Mark Warren, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $1.3M
Cory White, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $491,079
Dr. James Horton, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $151,082
Dr. Regina Dodis, D. O, D. O
Endocrinology, Diabetes & Metabolism — Payments: $11,168
Sandra Weber, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $7,533
Mojgan Rahmani, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $6,663